Dendritic cell defects in patients with cancer: mechanisms and significance.
Dendritic cells (DCs) are a complex network of antigen-presenting cells that have an essential role in the modulation of primary immunity. There has been increasing evidence that DCs isolated from patients with malignancy demonstrate functional deficiencies that inhibit the capacity to mount an effective anti-tumor response. In this issue of Breast Cancer Research, Pinzon-Charry and colleagues investigate one of the possible mechanisms by which tumors induce DC dysfunction to evade host immune surveillance. They demonstrate that DCs isolated from the circulation of patients with early-stage breast cancer exhibit increased rates of spontaneous apoptosis. In vitro studies suggest that a soluble factor secreted by breast cancer cells is responsible for this phenomenon. In contrast, ex vivo conditioning of DCs with CD-40 ligand and IL-12 was protective against tumor-induced apoptosis.
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.
Corrine
C
Lenahan
David
D
Avigan
D017209:Apoptosis; D001943:Breast Neoplasms / Q000503:physiopathology* / Q000628:therapy; D049109:Cell Proliferation; D003713:Dendritic Cells; D005260:Female; D006801:Humans; D007167:Immunotherapy; D018664:Interleukin-12 / Q000502:physiology*
D018664:Interleukin-12